Geltor, backed by Archer Daniels Midland and Wilbur-Ellis, is seeking between $50m and $100m in a series B round to scale its collagen manufacturing capabilities.
Geltor, a US-based collagen protein developer backed by agribusinesses Archer Daniels Midland and Wilbur-Ellis, is aiming to raise between $50m and $100m in series B funding, TechCrunch reported on Friday.
Founded in 2015, Geltor is working on cultured proteins, with an initial focus on collagen and gelatin – two additives that serve as thickening agents in food and cosmetics but are currently sourced as a byproduct of meat production.
The capital would allow Geltor to scale its manufacturing capabilities, following…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
